By detecting cancer as early as possible, there are always more treatment options available than when diagnosis occurs in stage IV. Inspire2Live is collaborating with SeekIn to make this dream a reality and hope is on the horizon because their products for detecting cancer at a very early stage are already available.The first implementation of the product(s) have started in 2023.
The founder and CEO of SeekIn, Mao Mao, is one of our patient advocates and, together with him and his team in Shenzhen, China, Inspire2Live is bringing early detection products to low- and middle-income countries. High-income countries will also have access however the most important driver for everyone involved is that these products become available for all.
